| RETIGMO BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)
1641237 28 Aug 2013 | on 22 Mar 2018 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejections; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, and pharmaceutical antibodies. | | | RETIGMO BRISTOL-MYERS SQUIBB COMPANY
(A DELAWARE CORPORATION)
1363545 13 Sep 2007 | on 02 Oct 2013 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, metabolic disorders, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejections; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, and pharmaceutical antibodies. | | 
